(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CHO PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CHO PHARMA

ST13

US500000086714741

Class

5

Filing

86714741

Registration

5313817

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

49

Latest update

12/01/2023

Trademark type

Word

Nice classes

5

Filing date

08/04/2015

Registration date

10/17/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/01/2023

Last transaction

12/01/2023

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

Taipei City, TW

Examiner

HERRERA-MARCUS, ROSELLE

Law office

N60

Current location

TMO LAW OFFICE 124

Holders and representatives

Holders

CHO PHARMA INC.
CHO PHARMA INC.

Representatives

Michael T. Smith BIRCH, STEWART, KOLASCH & BIRCH, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposesanti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Veterinary preparations for anti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Vaccines; Pharmaceutical preparations for human use for the prevention of tumorscancersimmune diseases/disorders infections and metabolic diseases; Biological preparations for medical purposes for the treatment of tumorscancersimmune diseases/disordersinfections and metabolic diseases; Capsules for medicines for the treatment of tumorscancersimmune diseases/disorders infections and metabolic diseases; Veterinary preparations for the treatment of tumorscancersimmune diseases/disordersinfections and metabolic diseases; Nutritional supplements; Dietary supplements for human health; Nutritional supplements for medical purposes for human boosting energypromoting human health; Chemical preparations for pharmaceutical purposesfor anti-tumorsanti-cancersanti-infectionsimmune regulationendocrine regulation and health improvement; Chemical preparations for medical purposesfor anti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Chemical preparations for veterinary purposes namelyfor anti-tumorsanti-cancersanti-infectionsimmune regulation and endocrine regulation; Vitamin nutritional supplements; Plant extract nutritional supplements; Diagnostic preparations for medical purposes; Surgical implants comprising of living tissues; Surgical adhesive tapes; Surgical dressings; Preparations for the treatment of burns

Publications

History of USPTO decisions and trademark events.

49 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

12/01/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

12/01/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/01/2023

ES8R

TEAS SECTION 8 RECEIVED

08/29/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/17/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/05/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/05/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/05/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/05/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/05/2020

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/17/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/14/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

09/07/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/06/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/06/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/31/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/29/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/29/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/04/2017

GNRT

NON-FINAL ACTION E-MAILED

03/04/2017

CNRT

NON-FINAL ACTION WRITTEN

03/04/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/10/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/09/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/09/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/13/2016

GNRT

NON-FINAL ACTION E-MAILED

09/13/2016

CNRT

NON-FINAL ACTION WRITTEN

09/13/2016

ZZBX

ALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION

09/13/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/29/2016

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

07/19/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/06/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/29/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/10/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/09/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/09/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/09/2016

GNRT

NON-FINAL ACTION E-MAILED

06/09/2016

CNRT

NON-FINAL ACTION WRITTEN

06/09/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/07/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/07/2016

ALIE

ASSIGNED TO LIE

06/03/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/23/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/23/2015

GNRT

NON-FINAL ACTION E-MAILED

11/23/2015

CNRT

NON-FINAL ACTION WRITTEN

11/23/2015

DOCK

ASSIGNED TO EXAMINER

11/16/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/08/2015

NWAP

NEW APPLICATION ENTERED

08/07/2015

Continuous trademark protection

Get notified about every new filing that threatens CHO PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.